• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number JHJR061002J
Device Problems Entrapment of Device (1212); Activation Failure (3270)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/05/2022
Event Type  malfunction  
Event Description
The following information was reported to gore: on (b)(6) 2022, this patient underwent endovascular procedure to treat a left superficial femoral artery occlusion using two drug-eluting stents (des, eluvia¿).When deploying the second des, the proximal part of the stent was deployed in the sheath unintentionally.The sheath was pulled without realizing that the proximal part of the des was deployed in the sheath, resulting in proximal migration of the des.Furthermore, the stent shrank and distorted during this process.Reportedly, mural thrombus was observed in the patient's vessel.For repair, a gore® viabahn® endoprosthesis with heparin bioactive surface (viabahn device) was used to reline the des.During the deployment of the viabahn device, the deployment line was caught by the stent of the des, resulting in incomplete deployment.The stent graft could not be fully deployed by moving the delivery catheter back and forth, and the viabahn device was removed with the sheath.At that time, the previously implanted two dess were also removed together.It was confirmed that a part of vessel intima was peeled by the des.The procedure was completed by implanting a new stent graft in the injured site.The patient tolerated the procedure.
 
Manufacturer Narrative
Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Manufacturer Narrative
The japan ifu for this product states: deployment of this product: do not deploy this product within stents or stent grafts other than this product.[there is a possibility that this product may not advance through a previously implanted stent, or that stent may interrupt deployment of this product].Gore requested further information regarding this procedure, including device serial number; however no further information has been reported to gore, therefore this investigation is considered complete.
 
Manufacturer Narrative
No device was returned to gore for evaluation.One photograph was returned to gore showing the removed viabahn device partially expanded within another stent.This supports the reported event of the deployment line becoming caught on an existing non-gore stent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
kaitlin barnash
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key13365899
MDR Text Key284811352
Report Number2017233-2022-02692
Device Sequence Number1
Product Code NIP
Combination Product (y/n)Y
Reporter Country CodeJA
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 05/25/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberJHJR061002J
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/05/2022
Initial Date FDA Received01/27/2022
Supplement Dates Manufacturer Received05/02/2022
05/02/2022
Supplement Dates FDA Received05/03/2022
05/26/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age76 YR
Patient SexMale
-
-